Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. (+--)-1-cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic Acid
2. (+--)-1-cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic Acid Monohydrochloride
3. 3-quinolinecarboxylic Acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-
4. 3-quinolinecarboxylic Acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-, Monohydrochloride, (+--)-
5. Grepafloxacin
6. Grepafloxacin Hcl
7. Opc 17116
8. Opc-17116
9. Raxar
1. 161967-81-3
2. Raxar
3. Grepafloxacin Hcl
4. Grepafloxacin Hydrochloride [usan]
5. Opc-17116
6. A4er1z8n9n
7. Grepafloxacin (hydrochloride)
8. 173689-78-6
9. 161967-81-3 (hcl)
10. 1-cyclopropyl-6-fluoro-5-methyl-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid Hydrochloride
11. Opc 17116
12. Dsstox_cid_26692
13. Dsstox_rid_81826
14. Dsstox_gsid_46692
15. 1-cyclopropyl-6-fluoro-5-methyl-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic Acid;hydrochloride
16. Opc 17116; Raxar; Vaxar; Dl-grepafloxacin Hydrochloride
17. 1-cyclopropyl-6-fluoro-5-methyl-7-(3-methylpiperazin-1-yl)-4-oxo-2,3-dihydroquinoline-3-carboxylic A
18. Cas-161967-81-3
19. Ncgc00167527-01
20. Unii-a4er1z8n9n
21. Lungaskin
22. Vaxar
23. Gpfx
24. Raxar (tn)
25. Schembl137804
26. Chembl1200393
27. Dtxsid0046692
28. Hy-a0147a
29. Grepafloxacin Hydrochloride (+-)-
30. Tox21_112524
31. Akos015962215
32. Tox21_112524_1
33. Grepafloxacin Hydrochloride (jan/usan)
34. Grepafloxacin Hydrochloride [mi]
35. Ncgc00167527-03
36. Ac-16082
37. Grepafloxacin Hydrochloride [mart.]
38. Grepafloxacin Hydrochloride [vandf]
39. Grepafloxacin Hydrochloride [who-dd]
40. Cs-0031245
41. D02178
42. Grepafloxacin Hydrochloride [orange Book]
43. 967g813
44. Q27273620
45. (+-)-1-cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic Acid Monohydrochloride
46. (+/-)-1-cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic Acid Monohydrochloride
47. 3-quinolinecarboxylic Acid, 1,4-dihydro-1-cyclopropyl-6-fluoro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-, Monohydrochloride, (+-)-
48. 3-quinolinecarboxylic Acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-, Monohydrochloride
49. 3-quinolinecarboxylic Acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-, Monohydrochloride, (+-)-
50. 3-quinolinecarboxylic Acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-, Monohydrochloride, (+/-)-
| Molecular Weight | 395.9 g/mol |
|---|---|
| Molecular Formula | C19H23ClFN3O3 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 3 |
| Exact Mass | 395.1411975 g/mol |
| Monoisotopic Mass | 395.1411975 g/mol |
| Topological Polar Surface Area | 72.9 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 636 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Topoisomerase II Inhibitors
Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
65
PharmaCompass offers a list of Grepafloxacin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Grepafloxacin manufacturer or Grepafloxacin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Grepafloxacin manufacturer or Grepafloxacin supplier.
PharmaCompass also assists you with knowing the Grepafloxacin API Price utilized in the formulation of products. Grepafloxacin API Price is not always fixed or binding as the Grepafloxacin Price is obtained through a variety of data sources. The Grepafloxacin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A GREPAFLOXACIN HYDROCHLORIDE manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of GREPAFLOXACIN HYDROCHLORIDE, including repackagers and relabelers. The FDA regulates GREPAFLOXACIN HYDROCHLORIDE manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. GREPAFLOXACIN HYDROCHLORIDE API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A GREPAFLOXACIN HYDROCHLORIDE supplier is an individual or a company that provides GREPAFLOXACIN HYDROCHLORIDE active pharmaceutical ingredient (API) or GREPAFLOXACIN HYDROCHLORIDE finished formulations upon request. The GREPAFLOXACIN HYDROCHLORIDE suppliers may include GREPAFLOXACIN HYDROCHLORIDE API manufacturers, exporters, distributors and traders.
GREPAFLOXACIN HYDROCHLORIDE Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of GREPAFLOXACIN HYDROCHLORIDE GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right GREPAFLOXACIN HYDROCHLORIDE GMP manufacturer or GREPAFLOXACIN HYDROCHLORIDE GMP API supplier for your needs.
A GREPAFLOXACIN HYDROCHLORIDE CoA (Certificate of Analysis) is a formal document that attests to GREPAFLOXACIN HYDROCHLORIDE's compliance with GREPAFLOXACIN HYDROCHLORIDE specifications and serves as a tool for batch-level quality control.
GREPAFLOXACIN HYDROCHLORIDE CoA mostly includes findings from lab analyses of a specific batch. For each GREPAFLOXACIN HYDROCHLORIDE CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
GREPAFLOXACIN HYDROCHLORIDE may be tested according to a variety of international standards, such as European Pharmacopoeia (GREPAFLOXACIN HYDROCHLORIDE EP), GREPAFLOXACIN HYDROCHLORIDE JP (Japanese Pharmacopeia) and the US Pharmacopoeia (GREPAFLOXACIN HYDROCHLORIDE USP).
